March 16, 2020
Dr. Jim Hu, a professor of urologic oncology at New York Presbyterian/Weill Cornell, in New York City, told Reuters Health by email, "The challenge of randomized trials for prostate cancer is the long period of time needed for meaningful differences to occur, and in turn, practice patterns change as we wait for these events." Read More.
